By Tracy Qu
Shares of ClouDr Group rose sharply in Hong Kong after the Chinese medical software provider said it will integrate AI firm DeepSeek's model into its core product.
The stock rose 12% to HK$1.81 in Thursday morning trade, extending year-to-date gains to 52.5% and outperforming the benchmark Hang Seng Index, which was up 0.1%.
The company, which provides digital solutions for managing chronic conditions, said it has integrated the DeepSeek-R1 model with its medical artificial-intelligence system ClouDr Brain to improve data analysis. This is expected to help hospitals and pharmacies enhance the use of ClouDr's AI system to manage patients with chronic medical conditions, it said.
"The integration of the DeepSeek-R1 model in ClouDr Brain combines advanced data analysis and AI technology to provide precise decision-making support for chronic disease management through big data analysis and machine learning algorithms," the company said.
Founded in 2014, ClouDr specializes in healthcare digitalization.
DeepSeek's R1 large-language model made waves when it was released in January for purportedly achieving high efficiency with lower-tech chips at cheaper costs. OpenAI CEO Sam Altman has called it "an impressive model."
Write to Tracy Qu at tracy.qu@wsj.com
(END) Dow Jones Newswires
February 05, 2025 22:15 ET (03:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.